CHICAGO, March 9 (Reuters) - U.S. regulators on Tuesday approved the use of Allergan Inc's wrinkle smoother Botox to treat spasms of the elbow, wrist and fingers in adults. The U.S. Food and Drug ...
Background OnabotulinumtoxinA has demonstrated significant benefit in adult focal spasticity. This study reviews the injection patterns (i.e., muscle distribution, dosing) of onabotulinumtoxinA for ...
Medical education and research, diversity in medicine, women in medicine, community engagement and health equity, clinical trials, treatment of rare neurologic disorders, spasticity and dystonia.
WASHINGTON — The Food and Drug Administration said Tuesday it approved Allergan’s botulinum-based drug Botox to treat spasms of the elbow, wrist and fingers. Botox is most famous for it’s ability to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback